Universität zu Köln

Journal Article

Di Tacchio, Mariangela, Macas, Jadranka, Weissenberger, Jakob, Sommer, Kathleen, Baehr, Oliver, Steinbach, Joachim P., Senft, Christian, Seifert, Volker, Glas, Martin, Herrlinger, Ulrich, Krex, Dietmar, Meinhardt, Matthias, Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Timmer, Marco, Goldbrunner, Roland, Deckert, Martina, Scheel, Andreas H., Buettner, Reinhard, Grauer, Oliver M., Schittenhelm, Jens, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Harter, Patrick N., Guenther, Stefan, Devraj, Kavi, Plate, Karl H. and Reiss, Yvonne (2019). Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF. Cancer Immunol. Res., 7 (12). S. 1910 - 1928. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 2326-6074

Heinzel, Alexander, Dedic, Daniela, Galldiks, Norbert, Lohmann, Philipp ORCID: 0000-0002-5360-046X, Stoffels, Gabriele, Filss, Christian P., Kocher, Martin, Migliorini, Filippo ORCID: 0000-0001-7220-1221, Dillen, Kim N. H., Geisler, Stefanie, Stegmayr, Carina, Willuweit, Antje, Sabel, Michael ORCID: 0009-0000-1485-7820, Rapp, Marion, Eble, Michael J., Piroth, Marc, Clusmann, Hans, Delev, Daniel, Bauer, Elena K., Ceccon, Garry, Dunkl, Veronika, Rosen, Jurij, Tscherpel, Caroline, Werner, Jan-Michael, Ruge, Maximilian I., Goldbrunner, Roland, Hampl, Jurgen, Weiss Lucas, Carolin, Herrlinger, Ulrich, Maurer, Gabriele D., Steinbach, Joachim P., Mauler, Joerg, Worthoff, Wieland A., Neumaier, Bernd N., Lerche, Christoph, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Shah, Nadim Jon, Mottaghy, Felix M. and Langen, Karl-Josef (2022). Two Decades of Brain Tumour Imaging with O-(2-[F-18]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Julich Experience. Cancers, 14 (14). BASEL: MDPI. ISSN 2072-6694

Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Haenel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Ruediger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tuettenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter and Glas, Martin (2016). Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. J. Clin. Oncol., 34 (14). S. 1611 - 1623. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Weller, Johannes ORCID: 0000-0001-5818-5392, Mack, Frederic, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Baehr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich (2019). Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. J. Neuro-Oncol., 144 (3). S. 501 - 510. NEW YORK: SPRINGER. ISSN 1573-7373

Maurer, Gabriele D., Brucker, Daniel P., Stoffels, Gabriele, Filipski, Katharina, Filss, Christian P., Mottaghy, Felix M., Galldiks, Norbert ORCID: 0000-0002-2485-1796, Steinbach, Joachim P., Hattingen, Elke ORCID: 0000-0002-8392-9004 and Langen, Karl-Josef ORCID: 0000-0003-1101-5075 (2020). F-18-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center Experience. J. Nucl. Med., 61 (4). S. 505 - 512. RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667

Mueller, Marguerite, Winz, Oliver, Gutsche, Robin, Leijenaar, Ralph T. H., Kocher, Martin, Lerche, Christoph, Filss, Christian P., Stoffels, Gabriele, Steidl, Eike, Hattingen, Elke, Steinbach, Joachim P., Maurer, Gabriele D., Heinzel, Alexander, Galldiks, Norbert, Mottaghy, Felix M., Langen, Karl-Josef and Lohmann, Philipp (2022). Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression. J. Neuro-Oncol., 159 (3). S. 519 - 530. NEW YORK: SPRINGER. ISSN 1573-7373

Schaefer, Niklas, Proescholdt, Martin, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Grauer, Oliver, Goldbrunner, Roland, Friedrich, Franziska, Rohde, veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Grau, Stefan, Haenel, Mathias, Schnell, Oliver, Krex, Dietmar, Vajkoczy, Peter, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Mack, Frederic, Schaub, Christina, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Niessen, Michael, Kebir, Sied, Leutgeb, Barbara, Urbach, Horst, Belka, Claus, Stummer, Walter, Glas, Martin and Herrlinger, Ulrich (2018). Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro-Oncology, 20 (7). S. 975 - 986. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Baehr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich and Glas, Martin (2018). Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. J. Cancer Res. Clin. Oncol., 144 (8). S. 1581 - 1590. NEW YORK: SPRINGER. ISSN 1432-1335

Scholz, Alexander, Harter, Patrick N. ORCID: 0000-0001-5530-6910, Cremer, Sebastian, Yalcin, Burak H., Gurnik, Stefanie, Yamaji, Maiko, Di Tacchio, Mariangela, Sommer, Kathleen, Baumgarten, Peter, Baehr, Oliver, Steinbach, Joachim P., Trojan, Joerg, Glas, Martin, Herrlinger, Ulrich, Krex, Dietmar, Meinhardt, Matthias, Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Timmer, Marco, Goldbrunner, Roland, Deckert, Martina, Braun, Christian, Schittenhelm, Jens, Frueh, Jochen T., Ullrich, Evelyn ORCID: 0000-0001-8530-1192, Mittelbronn, Michel, Plate, Karl H. and Reiss, Yvonne (2016). Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol. Med., 8 (1). S. 39 - 58. HOBOKEN: WILEY-BLACKWELL. ISSN 1757-4684

Steidl, Eike, Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Abu Hmeidan, Sarah, Polomac, Nenad, Filss, Christian P., Galldiks, Norbert, Lohmann, Philipp, Keil, Fee, Filipski, Katharina, Mottaghy, Felix M., Shah, Nadim Jon, Steinbach, Joachim P., Hattingen, Elke and Maurer, Gabriele D. . Sequential implementation of DSC-MR perfusion and dynamic [F-18]FET PET allows efficient differentiation of glioma progression from treatment-related changes. Eur. J. Nucl. Med. Mol. Imaging. NEW YORK: SPRINGER. ISSN 1619-7089

Weller, Johannes ORCID: 0000-0001-5818-5392, Schaefer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Schlegel, Uwe, Sabel, Michael ORCID: 0009-0000-1485-7820, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Pietsch, Torsten, Tzaridis, Theophilos, Zeyen, Thomas, Borger, Valeri, Guresir, Erdem, Vatter, Hartmut, Herrlinger, Ulrich and Schneider, Matthias (2022). Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS. J. Neuro-Oncol., 159 (1). S. 95 - 102. NEW YORK: SPRINGER. ISSN 1573-7373

Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael ORCID: 0009-0000-1485-7820, Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Gueresir, Erdem, Schmid, Matthias ORCID: 0000-0002-0788-0317, Schuss, Patrick ORCID: 0000-0002-5806-2576, Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank ORCID: 0000-0003-4892-6104, Herrlinger, Ulrich and Schneider, Matthias (2022). Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. Trials, 23 (1). LONDON: BMC. ISSN 1745-6215